• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Update on asthma prevalence in severe COVID-19 patients.

作者信息

Morais-Almeida Mário, Barbosa Miguel T, Sousa Cláudia S, Aguiar Rita, Bousquet Jean

机构信息

Allergy Centre, CUF Descobertas Hospital, Lisbon, Portugal.

Portuguese Association of Asthmatics (APA), Porto, Portugal.

出版信息

Allergy. 2021 Mar;76(3):953-954. doi: 10.1111/all.14482. Epub 2020 Jul 22.

DOI:10.1111/all.14482
PMID:32639631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361842/
Abstract
摘要

相似文献

1
Update on asthma prevalence in severe COVID-19 patients.重症 COVID-19 患者哮喘患病率的最新情况。
Allergy. 2021 Mar;76(3):953-954. doi: 10.1111/all.14482. Epub 2020 Jul 22.
2
Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.2020年疫情期间一项横断面研究：SARS-CoV-2逆转录实时聚合酶链反应（rtRT-PCR）检测呈阳性的墨西哥儿童和成人中哮喘的低患病率
Allergol Immunopathol (Madr). 2021 May 1;49(3):1-7. doi: 10.15586/aei.v49i3.7. eCollection 2021.
3
[Asthma and COVID-19].[哮喘与2019冠状病毒病]
Rev Alerg Mex. 2022;69 Suppl 1:s15-s23. doi: 10.29262/ram.v69iSupl1.1009.
4
Severe asthma and COVID-19: lessons from the first wave.严重哮喘与 COVID-19：来自第一波疫情的教训。
J Asthma. 2022 Feb;59(2):239-242. doi: 10.1080/02770903.2020.1861622. Epub 2020 Dec 16.
5
Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.为何 COVID-19 患者的哮喘发病率较低，这证明了将 EDTA 溶液重新用于预防和治疗 COVID-19 疾病是合理的。
Med Hypotheses. 2020 Nov;144:110027. doi: 10.1016/j.mehy.2020.110027. Epub 2020 Jun 26.
6
Asthma and COVID-19: lessons learned and questions that remain.哮喘与 COVID-19：经验教训与未解之谜
Expert Rev Respir Med. 2021 Nov;15(11):1377-1386. doi: 10.1080/17476348.2021.1985763. Epub 2021 Oct 14.
7
Prevalence and Influence of COVID-19 in Asthma Control and Lung Function in Severe Asthma Patients Receiving Biological Treatment.新型冠状病毒肺炎在接受生物治疗的重度哮喘患者的哮喘控制及肺功能方面的患病率和影响
J Investig Allergol Clin Immunol. 2021 Jul 26;31(4):362-363. doi: 10.18176/jiaci.0695. Epub 2021 Apr 15.
8
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎：分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
9
Low prevalence of post-COVID-19 syndrome in patients with asthma.哮喘患者中新冠后综合征的低患病率。
J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.023. Epub 2021 Apr 2.
10
The Impact of Asthma on Mortality in Patients With COVID-19.哮喘对COVID-19患者死亡率的影响。
Chest. 2020 Dec;158(6):2290-2291. doi: 10.1016/j.chest.2020.05.575. Epub 2020 Jun 6.

引用本文的文献

1
A systematic two-sample and bidirectional MR process highlights a unidirectional genetic causal effect of allergic diseases on COVID-19 infection/severity.一项系统的两样本双向 MR 分析过程强调了过敏性疾病对 COVID-19 感染/严重程度的单向遗传因果效应。
J Transl Med. 2024 Jan 23;22(1):94. doi: 10.1186/s12967-024-04887-4.
2
Asthma May Not be a Potential Risk Factor for Severe COVID-19 Illness: A Scoping Review.哮喘可能不是重症 COVID-19 疾病的潜在风险因素：一项范围综述。
Environ Health Insights. 2024 Jan 3;18:11786302231221925. doi: 10.1177/11786302231221925. eCollection 2024.
3
Epidemiology of Asthma in Patients with COVID-19: Investigation of Respiratory Allergy as a Risk Factor for COVID-19 Severity.2019冠状病毒病患者的哮喘流行病学：将呼吸道过敏作为2019冠状病毒病严重程度风险因素的调查
Tanaffos. 2022 Feb;21(2):186-192.
4
Causal Association and Shared Genetics Between Asthma and COVID-19.哮喘和 COVID-19 之间的因果关联和共同遗传。
Front Immunol. 2022 Mar 21;13:705379. doi: 10.3389/fimmu.2022.705379. eCollection 2022.
5
Case Report: Self-Administration of Omalizumab in an Adolescent With Severe Asthma During SARS-CoV-2 Infection.病例报告：一名重度哮喘青少年在感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）期间自行使用奥马珠单抗。
Front Pediatr. 2021 Dec 6;9:675281. doi: 10.3389/fped.2021.675281. eCollection 2021.
6
Recent advances and developments in COVID-19 in the context of allergic diseases.新冠病毒肺炎在过敏性疾病背景下的最新进展与动态
Clin Transl Allergy. 2021 Sep;11(7):e12065. doi: 10.1002/clt2.12065.
7
Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification.COVID-19中的哮喘表型、合并症及疾病活动度：风险分层的必要性
Allergy. 2021 Mar;76(3):955-956. doi: 10.1111/all.14537. Epub 2020 Aug 24.
8
Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS-CoV-2.病毒与哮喘：常见呼吸道病毒在哮喘中的作用及其对 SARS-CoV-2 的潜在意义。
Immunology. 2020 Oct;161(2):83-93. doi: 10.1111/imm.13240. Epub 2020 Aug 17.

本文引用的文献

1
Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review.哮喘与2019年冠状病毒病大流行：文献综述
Int Arch Allergy Immunol. 2020;181(9):680-688. doi: 10.1159/000509057. Epub 2020 Jun 9.
2
Is asthma protective against COVID-19?哮喘对新型冠状病毒肺炎有保护作用吗？
Allergy. 2021 Mar;76(3):866-868. doi: 10.1111/all.14426. Epub 2020 Jun 17.
3
COVID-19 and asthma: To have or not to have T2 inflammation makes a difference?新型冠状病毒肺炎与哮喘：是否存在2型炎症会有不同影响吗？
Pulmonology. 2020 Sep-Oct;26(5):261-263. doi: 10.1016/j.pulmoe.2020.05.003. Epub 2020 May 19.
4
Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.早期皮质类固醇治疗对成年患者血浆中严重急性呼吸综合征相关冠状病毒RNA浓度的影响。
J Clin Virol. 2004 Dec;31(4):304-9. doi: 10.1016/j.jcv.2004.07.006.